What is the Wolverine stack?
“Wolverine stack” is a reported name for BPC-157 plus TB-500. It identifies a pairing in peptide-stack descriptions, not a standardised treatment. The name alone does not specify the exact TB-500 substance, amount, route or product quality.
The two names on the list
Swipe or scroll sideways to compare all columns.
| Component | What to distinguish |
|---|---|
| BPC-157 | Ingredient identity from claims made for the blend |
| TB-500 | The supplied molecule from the parent thymosin-beta-4 protein |
| Wolverine | A reported pair name; the name does not establish a validated protocol |
Why the TB-500 detail matters
FDA’s safety note explicitly names thymosin beta-4 fragment LKKTETQ, also known as TB-500. A study using a parent protein, fragment or different preparation is not automatically a study of the vial sold under the same nickname. Match the substance before importing a result.
What the sources do and do not establish
The stack glossary is used here only to document the pairing name. It is not clinical evidence for recovery claims. FDA separately describes missing or limited safety information, possible immune reactions and peptide-related impurity concerns. Neither source supplies a dosing protocol for this combination.

Use the table and its sources
Related reading
Source-linked editorial synthesis, prepared with AI assistance. This is not a clinician review or a personalised treatment recommendation. Corrections: editorial standards.

